Skip to content

Influence of MCT and caffeine on ketogenesis (ßHB)

Influence of MCT and caffeine on ketogenesis (ßHB) - MCTCoffKeto

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00015098
Enrollment
8
Registered
2018-07-13
Start date
2018-07-25
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy sujects

Interventions

Group 1: Study Day 1: 250 ml of decaffeinated coffee (placebo control) Group 2: Study Day 2: 250 ml decaffeinated coffee + 150 mg caffeine Group 3: Study Day 3: 250 ml decaffeinated coffee + 10 g MCT

Sponsors

Fachhochschule Münster
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Age between 18 - 30 years, male, female (equal distribution), no known metabolic disease (eg disturbance of lipid metabolism, diabetes mellitus type 1 or 2), no intake of medication (exception: contraceptives), no chronic health impairment (eg cardiovascular diseases, thyroid defects, intestinal diseases), no mental or linguistic limitations, No low carbohydrate, vegan or other diet with permanent reduction of carbohydrate intake (references of the German Nutrition Society: at least 50% carbohydrate), Signature of the consent form, Non smoking

Exclusion criteria

Exclusion criteria: Ingestion of nutritional supplements with effects on lipid metabolism (eg MCT), Pregnancy / Breastfeeding, simultaneous participation in other studies / study programs, taking medication (exeption:contraceptives), severe underlying disease (eg cancer), mental illnesses (eg depression, schizophrenia), existing disease of the metabolism, chronic illness, lower deviations from the references of the German Nutrition Society for healthy mixed food (<50% carbohydrate / day), Blood donation within the last 3 months before the start of the study, Incompatibility with MCT and / or caffeine, smoker

Design outcomes

Primary

MeasureTime frame
ß-hydroxybutyrate (mmol/L) in capillary blood at t0 (baseline) and tmax (primary outcome). Measuring over a period of 4 hours every 40 minutes.

Secondary

MeasureTime frame
tolerability (self documentation of the subjects, during intervention time), sensory interview (description of taste, odor, mouthfeel during intake of test solution), blood parameters: glucose (every 40 minutes over 4 h), respiratory measurement: acetone, saliva analysis: caffeine, theobromine, theophylline, Urinalysis: caffeine, urine test strips (leucocytes, nitrite, pH, protein, glucose, ketone, urobilinogen, bilirubin, blood)

Countries

Germany

Contacts

Public ContactAnna Baumeister

Fachhochschule Münster

anna.baumeister@fh-muenster.de02518365497

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026